Uncomplicated Malaria Co-infection Does Not Worsen COVID-19 Outcomes in West Africa
A prospective cohort study published in The Lancet Global Health investigates the impact of acute uncomplicated malaria co-infection on the duration and severity of COVID-19 in western Kenya and Burkina Faso. The research, known as the MALCOV study, reveals that when malaria is appropriately treated, the co-infection does not adversely affect the progression of COVID-19. Furthermore, the study provides serological evidence suggesting that individuals with a history of lifelong malaria exposure may possess some level of protection against severe COVID-19 outcomes. Specifically, these exposed individuals demonstrated faster resolution of symptoms compared to those without such exposure. These findings challenge earlier concerns regarding potential negative interactions between malaria and SARS-CoV-2 infections, highlighting the importance of effective malaria treatment protocols. The study contributes valuable insights into the complex interplay between endemic tropical diseases and global pandemics, offering hope that prior immune responses to malaria might mitigate certain aspects of COVID-19 severity in affected populations.
Wire timeline
Uncomplicated Malaria Co-infection Does Not Worsen COVID-19 Outcomes in West Africa
A prospective cohort study published in The Lancet Global Health investigates the impact of acute uncomplicated malaria co-infection on the duration and severity of COVID-19 in western Kenya and Burkina Faso. The research, known as the MALCOV study, reveals that when malaria is appropriately treated, the co-infection does not adversely affect the progression of COVID-19. Furthermore, the study provides serological evidence suggesting that individuals with a history of lifelong malaria exposure may possess some level of protection against severe COVID-19 outcomes. Specifically, these exposed individuals demonstrated faster resolution of symptoms compared to those without such exposure. These findings challenge earlier concerns regarding potential negative interactions between malaria and SARS-CoV-2 infections, highlighting the importance of effective malaria treatment protocols. The study contributes valuable insights into the complex interplay between endemic tropical diseases and global pandemics, offering hope that prior immune responses to malaria might mitigate certain aspects of COVID-19 severity in affected populations.
The Lancet Global Health